FDA-cleared profile

Brainomix 360 Hyperdensity

Brainomix Limited · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Clinical role
A parallel workflow tool that uses a locked AI/ML algorithm to outline intracranial hyperdense areas on NCCT head scans and quantify their volume; its DICOM output is sent to PACS with the original NCCT series for physician review.
Images and patients
CT/CTA · Brain
Key limitation
Keep in mind: Does not provide lateral-ventricle volume or midline shift and is not a replacement for physician image review.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Brain Input: Adult single-timepoint non-contrast head CT.
  • Who uses it?Intended users: Medical imaging professionals and trained clinicians.
  • What does the software produce?Output: DICOM summary and segmentation series with RGB overlays and hyperdensity volume labels; colors are only for visual differentiation between segmented regions and have no meaning on their own.
  • What is its most important limitation?Key limitation: Does not provide lateral-ventricle volume or midline shift and is not a replacement for physician image review.

Clinical takeaway. Clinical role: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Evidence takeaway. Evidence from the reviewed source record: Regulatory segmentation agreement testing is submission-specific; clinical diagnostic-performance metrics were not abstracted.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
A parallel workflow tool that uses a locked AI/ML algorithm to outline intracranial hyperdense areas on NCCT head scans and quantify their volume; its DICOM output is sent to PACS with the original NCCT series for physician review.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "uses a locked artificial intelligence machine learning (AI/ML) algorithm to process non-contrast head CT (NCCT) scans to outline intracranial hyperdense areas and then quantify the volume of intracranial hyperdensities" … "Brainomix 360 Hyperdensity is a parallel workflow tool installed across the neurology network in healthcare facilities to identify and communicate images". Read from the exact FDA decision document on 2026-11-14.

Required input
Adult single-timepoint non-contrast head CT.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Output and clinician action
DICOM summary and segmentation series with RGB overlays and hyperdensity volume labels; colors are only for visual differentiation between segmented regions and have no meaning on their own.
  • Exact FDA submission
  • Checked 2026-09-19

The exact device description states the DICOM series, RGB overlay, volume-label, and color-meaning boundaries.

Care setting
Adult
  • Exact FDA submission
  • Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Intended users
Medical imaging professionals and trained clinicians.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet identifies medical imaging professionals as primary users and the intended environment/users as trained clinicians.

Limitations
Does not provide lateral-ventricle volume or midline shift and is not a replacement for physician image review.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Evidence summary
Regulatory segmentation agreement testing is submission-specific; clinical diagnostic-performance metrics were not abstracted.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Regulatory segmentation agreement testing is submission-specific; clinical diagnostic-performance metrics were not abstracted.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05
Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Brainomix 360 Hyperdensity regulatory segmentation validation

  • DesignSegmentation validation against trained-radiologist reference.
  • PopulationAdult non-contrast CT; cohort size not reported in the reviewed summary.
  • Scopeexact submission
  • Tested versionBrainomix 360 Hyperdensity configuration K260406
  • IndependenceIndependence not established

K260406

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Adult single-timepoint non-contrast head CT.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K260406: Brainomix 360 Hyperdensity

  2. Routing

    Source context, not route validation: Automated DICOM routing sends original images and results to preconfigured PACS destinations; the DICOM Network Integration Module uses DICOM C-STORE.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · Brainomix 360 Hyperdensity: K260406 clearance and 510(k) summary

  3. AI processing

    Source context, not route validation: Software may be deployed as a physical server or virtual-machine software appliance.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · Brainomix 360 Hyperdensity: K260406 clearance and 510(k) summary

  4. Returned objects

    Source context, not route validation: DICOM summary and segmentation series with RGB overlays and hyperdensity volume labels; colors are only for visual differentiation between segmented regions and have no meaning on their own.

    Scope: Exact FDA submission. The exact device description states the DICOM series, RGB overlay, volume-label, and color-meaning boundaries.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K260406: Brainomix 360 Hyperdensity

  5. Viewer/worklist/report

    Unresolved route: DICOM summary and segmentation series with RGB overlays and hyperdensity volume labels; colors are only for visual differentiation between segmented regions and have no meaning on their own.

    Scope: Exact FDA submission. The exact device description states the DICOM series, RGB overlay, volume-label, and color-meaning boundaries.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K260406: Brainomix 360 Hyperdensity

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Software may be deployed as a physical server or virtual-machine software appliance.
  • Exact FDA submission
  • Checked 2026-09-05
Integration
Automated DICOM routing sends original images and results to preconfigured PACS destinations; the DICOM Network Integration Module uses DICOM C-STORE.
  • Exact FDA submission
  • Checked 2026-09-05
Security
Brainomix's current official FAQ describes ISO 27001, GDPR, and DPA controls for the current Brainomix 360 family; this does not establish certificate scope, expiry, deployed configuration, or exact K243294 security controls.
  • Product family
  • Checked 2026-10-25

Obtain current certificate scope, data-processing terms, hosting region, encryption, identity/access, audit, retention, and incident-response evidence for the deployed release.

Training
Current Brainomix FAQ describes installation/go-live testing and group training/manuals for licensed users.
  • Product family
  • Checked 2026-09-05
Monitoring
The PCCP permits model retraining and threshold adjustment within the cleared indications; models are locked before release and do not continuously learn.
  • Exact FDA submission
  • Checked 2026-09-05

Family implementation support

Managed-appliance deployment, PACS protocol setup and go-live testing are described by the vendor.

product family · checked 2026-09-05
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260406
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet identifies non-contrast CT as the supported imaging modality. Controlled directory display reconciled from exact FDA wording: Non-Contrast CT (NCCT). -> CT/CTA.

Anatomy
Brain
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact comparison table identifies Head as the anatomical region. Controlled directory display reconciled from exact FDA wording: Head. -> Brain.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-12
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-19Last searched
25Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

No stored literature or trial candidates; empty metadata snapshots were screened. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, vendor documentation, fda decision summary, vendor product page, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-06 - Exact product version
  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Brainomix 360 reimbursement CPT NTAP"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No Brainomix page naming coding or payment for this product was found. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

9 sources - 3 history items

Source ledger

  1. FDA K260406: Brainomix 360 Hyperdensity

    U.S. Food and Drug Administration - Published 2026-06-12 - Accessed 2026-09-19

    Scope: purpose, input, limitations, modality, anatomy, intendedUsers, output, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Brainomix 360 Hyperdensity model card (K260406)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Brainomix 360 Hyperdensity: K260406 clearance and 510(k) summary

    US Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinical, implementation, evidence

  8. Brainomix support and trust-center FAQ

    Brainomix - Accessed 2026-09-05

    Scope: product_family_implementation

  9. Brainomix 360 official FAQ

    Brainomix Limited - Accessed 2026-09-07

    Scope: productFamily, implementationCapabilities, security, training

Research history

  1. K260406 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251151

Rapid CTA 360

iSchemaView

Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-07-16
FDA-cleared K250354

Viz Subdural+, Viz SUBDURAL PLUS

Viz.ai, Inc.

Authorized purpose: Viz Subdural+ labels, visualizes, and quantifies subdural collections from single-time-point non-contrast head CT, reporting collection grayscale value, total volume, widest width, and midline shift as annotated DICOM images for physician review with original CT.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-06-10
FDA-cleared K243378

Rapid MLS

iSchemaview Inc.

Authorized purpose: Brain midline-shift measurement on adult non-contrast CT

Modality
CT/CTA
Anatomy
Brain
Decision
2025-05-28
FDA-cleared K243294

Brainomix 360 e-ASPECTS

Brainomix Limited

Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.

Modality
CT/CTA
Anatomy
Brain
Decision
2025-02-14

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history